| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Common Stock | 7,692,298 | $146,153,662 | $19.00 | 28 Jun 2021 | Indirect |
| Savara Inc | 10%+ Owner | Common Stock | 24,471,264 | $108,897,125 | $4.45 | 17 Jul 2023 | Indirect |
| Korro Bio, Inc. | 10%+ Owner | Common Stock | 1,090,793 | $61,084,408 | $56.00 | 22 Apr 2024 | Indirect |
| MBX Biosciences, Inc. | Director, 10%+ Owner | Common Stock | 3,614,486 | $38,638,855 | $10.69 | 16 Sep 2024 | Indirect |
| RHYTHM PHARMACEUTICALS, INC. | Director | Common Stock | 7,000 | $412,790 | $58.97 | 18 Jun 2025 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | Director | Common Stock | 5,771 | $340,315 | $58.97 | 18 Jun 2025 | Indirect |
| OnKure Therapeutics, Inc. | Director | Class A Common Stock | 15,310 | $45,930 | $3.00 | 31 Dec 2025 | Direct |
| RHYTHM PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 4,712 | $0 | $39.10 | 24 Jun 2025 | Direct |
| NeueHealth, Inc. | Director, 10%+ Owner | Common Stock | 0 | $0 | $6.84 | 02 Oct 2025 | Indirect |
| Trevi Therapeutics, Inc. | Director | Nonstatutory Stock Option (right to buy) | 45,000 | 11 Jun 2025 | Direct | ||
| SYNLOGIC, INC. | Director | Stock Option (right to buy) | 30,000 | 22 Jun 2023 | Direct | ||
| Inozyme Pharma, Inc. | Director | Stock Option (right to buy) | 28,000 | 18 Jun 2024 | Direct | ||
| Senti Biosciences, Inc. | Director | Stock Option (Right to Buy) | 21,950 | 25 Jun 2025 | Direct | ||
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 17,000 | 02 Jun 2022 | Direct | ||
| MBX Biosciences, Inc. | Director, 10%+ Owner | Stock option (right to buy) | 16,000 | 05 Jun 2025 | Direct | ||
| OnKure Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,650 | 28 May 2025 | Direct | ||
| RHYTHM PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 7,037 | 24 Jun 2025 | Direct | ||
| Akouos, Inc. | Director | Stock Option (right to buy) | 0 | 01 Dec 2022 | Direct | ||
| MBX Biosciences, Inc. | Director, 10%+ Owner | Series A Convertible Preferred Stock | 0 | 16 Sep 2024 | Indirect | ||
| MBX Biosciences, Inc. | Director, 10%+ Owner | Series B Convertible Preferred Stock | 0 | 16 Sep 2024 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series A-2 convertible preferred stock | 0 | 28 Jun 2021 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | 28 Jun 2021 | Indirect | |
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series C convertible preferred Stock | 0 | $2.96 | 28 Jun 2021 | Indirect | |
| NeueHealth, Inc. | Director, 10%+ Owner | Series A Convertible Perpetual Preferred Stock | 0 | 02 Oct 2025 | Indirect | ||
| NeueHealth, Inc. | Director, 10%+ Owner | Series B Convertible Perpetual Preferred Stock | 0 | 02 Oct 2025 | Indirect | ||
| NeueHealth, Inc. | Director, 10%+ Owner | Warrant (Right to Buy) | 0 | 02 Oct 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | 31 Dec 2025 | 1 | $0 | 4 | Director | 02 Jan 2026, 16:16 |
| NEUE | NeueHealth, Inc. | 02 Oct 2025 | 23 | +$9.58 | 4 | Director, 10%+ Owner | 06 Oct 2025, 17:50 |
| OKUR | OnKure Therapeutics, Inc. | 30 Sep 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 16:29 |
| OKUR | OnKure Therapeutics, Inc. | 30 Jun 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 16:33 |
| SNTI | Senti Biosciences, Inc. | 25 Jun 2025 | 1 | $0 | 4 | Director | 27 Jun 2025, 19:02 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 24 Jun 2025 | 2 | $0 | 4 | Director | 26 Jun 2025, 16:45 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director | 23 Jun 2025, 16:57 |
| TRVI | Trevi Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:09 |
| MBX | MBX Biosciences, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 06 Jun 2025, 11:29 |
| OKUR | OnKure Therapeutics, Inc. | 28 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 17:05 |
| OKUR | OnKure Therapeutics, Inc. | 31 Mar 2025 | 1 | $0 | 4 | Director | 02 Apr 2025, 16:48 |
| SNTI | Senti Biosciences, Inc. | 07 Mar 2025 | 1 | $0 | 4 | Director | 11 Mar 2025, 16:28 |
| OKUR | OnKure Therapeutics, Inc. | 04 Oct 2024 | 1 | $0 | 4 | Director | 08 Oct 2024, 19:27 |
| NEUE | NeueHealth, Inc. | 01 Oct 2024 | 2 | $0 | 4 | 10%+ Owner | 03 Oct 2024, 18:37 |
| MBX | MBX Biosciences, Inc. | 16 Sep 2024 | 5 | +$8,000,000 | 4 | Director, 10%+ Owner | 17 Sep 2024, 20:28 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 1 | $0 | 4 | Director, 10%+ Owner | 13 Sep 2024, 17:11 |
| MBX | MBX Biosciences, Inc. | 12 Sep 2024 | 0 | $0 | 3 | Director, 10%+ Owner | 12 Sep 2024, 19:31 |
| SNTI | Senti Biosciences, Inc. | 10 Jul 2024 | 1 | $0 | 4 | Director | 12 Jul 2024, 16:30 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 21 Jun 2024 | 2 | $0 | 4 | Director | 25 Jun 2024, 16:38 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 18 Jun 2024 | 2 | $0 | 4 | Director | 20 Jun 2024, 21:43 |
| INZY | Inozyme Pharma, Inc. | 18 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 16:30 |
| TRVI | Trevi Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 16:40 |
| KRRO | Korro Bio, Inc. | 22 Apr 2024 | 1 | +$999,992 | 4 | 10%+ Owner | 24 Apr 2024, 17:00 |
| NEUE | NeueHealth, Inc. | 08 Apr 2024 | 2 | $0 | 4 | 10%+ Owner | 10 Apr 2024, 19:21 |
| NEUE | Bright Health Group Inc. | 19 Dec 2023 | 1 | $0 | 4 | 10%+ Owner | 21 Dec 2023, 17:01 |
| KRRO | Korro Bio, Inc. | 03 Nov 2023 | 0 | $0 | 3 | 10%+ Owner | 07 Nov 2023, 21:31 |
| NEUE | Bright Health Group Inc. | 31 Oct 2023 | 1 | $0 | 4 | 10%+ Owner | 02 Nov 2023, 18:48 |
| NEUE | Bright Health Group Inc. | 15 Sep 2023 | 1 | $0 | 4 | 10%+ Owner | 19 Sep 2023, 19:26 |
| NEUE | Bright Health Group Inc. | 11 Aug 2023 | 1 | $0 | 4 | 10%+ Owner | 15 Aug 2023, 22:58 |
| SVRA | Savara Inc | 17 Jul 2023 | 1 | +$999,999 | 4 | 10%+ Owner | 19 Jul 2023, 19:10 |
| TRVI | Trevi Therapeutics, Inc. | 28 Jun 2023 | 1 | $0 | 4 | Director | 30 Jun 2023, 16:14 |
| SYBX | SYNLOGIC, INC. | 22 Jun 2023 | 1 | $0 | 4 | Director | 26 Jun 2023, 15:46 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 21 Jun 2023 | 2 | $0 | 4 | Director | 23 Jun 2023, 16:58 |
| SNTI | Senti Biosciences, Inc. | 16 Jun 2023 | 1 | $0 | 4 | Director | 21 Jun 2023, 19:24 |
| INZY | Inozyme Pharma, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Director | 15 Jun 2023, 16:16 |
| OKUR | Reneo Pharmaceuticals, Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 20:09 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 02 Mar 2023 | 1 | $0 | 4 | Director | 06 Mar 2023, 12:47 |
| /report/000120919123000237-mathers-edward-t-2023-01-01 | ObsEva SA | 01 Jan 2023 | 0 | $0 | 3 | Director | 03 Jan 2023, 15:33 |
| /report/000120919122059455-mathers-edward-t-2022-12-01 | Akouos, Inc. | 01 Dec 2022 | 1 | $0 | 4 | Director | 02 Dec 2022, 16:09 |
| NEUE | Bright Health Group Inc. | 17 Oct 2022 | 2 | +$137,700,000 | 4 | 10%+ Owner | 19 Oct 2022, 19:59 |
| SNTI | Senti Biosciences, Inc. | 13 Jul 2022 | 1 | $0 | 4 | Director | 15 Jul 2022, 18:09 |
| /report/000120919122039500-mathers-edward-t-2022-06-23 | Akouos, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 17:08 |
| TRVI | Trevi Therapeutics, Inc. | 23 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 17:04 |
| INZY | Inozyme Pharma, Inc. | 10 Jun 2022 | 1 | $0 | 4 | Director | 14 Jun 2022, 16:32 |
| SYBX | SYNLOGIC, INC. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 16:45 |
| SNTI | Senti Biosciences, Inc.\ | 08 Jun 2022 | 0 | $0 | 3 | Director | 15 Jun 2022, 19:05 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:35 |
| MIRM | Mirum Pharmaceuticals, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 06 Jun 2022, 18:23 |
| OKUR | Reneo Pharmaceuticals, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 17:26 |
| TRVI | Trevi Therapeutics, Inc. | 11 Apr 2022 | 2 | +$7,500,001 | 4 | Director | 13 Apr 2022, 17:32 |
| NEUE | Bright Health Group Inc. | 03 Jan 2022 | 0 | $0 | 3 | 10%+ Owner | 05 Jan 2022, 17:05 |
| GLUE | Monte Rosa Therapeutics, Inc. | 28 Jun 2021 | 7 | +$19,950,000 | 4 | 10%+ Owner | 30 Jun 2021, 18:06 |
| /report/000120919121043357-mathers-edward-t-2021-06-24 | Akouos, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 25 Jun 2021, 17:49 |
| NEUE | Bright Health Group Inc. | 24 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 24 Jun 2021, 21:29 |
| INZY | Inozyme Pharma, Inc. | 23 Jun 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 17:32 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 23 Jun 2021, 21:12 |
| TRVI | Trevi Therapeutics, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 17:16 |
| SYBX | SYNLOGIC, INC. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 18:23 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 09 Jun 2021 | 1 | $0 | 4/A | Director | 16 Jun 2021, 16:16 |
| MIRM | Mirum Pharmaceuticals, Inc. | 04 Jun 2021 | 1 | $0 | 4 | Director | 08 Jun 2021, 16:38 |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | 09 Jun 2011 | 1 | $0 | 4 | Director | 11 Jun 2021, 17:39 |